GL1X · GenesisL1 explorer

MolNFT v1 · #107357 · protein

The crystal structure of the terminal R domain from the myxalamid pks- nrps biosynthetic pathway

4U7W · Mxaa: “The crystal structure of the terminal R domain from the myxalamid pks- nrps biosynthetic pathway”. X-ray diffraction, 1 ligand (NDP), 7 pockets (best druggability 0.86). MolNFT v1 #107357 on GenesisL1: 3D structure, binding…

PDB
4U7W
Type
protein
Length
784 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mxaa
UniProt
Q93TX2
Ligands
NDP
Pockets
7 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMxaaprotein39045% helix, 13% strandQ93TX2
BMxaaprotein39445% helix, 13% strandQ93TX2

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111050.860.8793NDP
211200.860.8687NDP
31070.410.7624empty
4950.400.7724empty
5690.360.7713empty

Interfaces

1 interface between chains.

  • A–B · 700 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 18 modified (engineered).

Compared structures

  • 4U7W · The crystal structure of the terminal R domain from the myxalamid PKS-NRPS biosynthetic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.